Lialda Dosage

Generic name: MESALAMINE 1.2g
Dosage form: tablet, delayed release
Drug class: 5-aminosalicylates

Medically reviewed by Drugs.com. Last updated on Oct 24, 2023.

Administration Instructions

Evaluate renal function prior to initiation of LIALDA and periodically while on therapy.
Swallow LIALDA tablets whole; do not split or crush.
Administer LIALDA tablets with food.
Drink an adequate amount of fluids.

Adults

The recommended dosage for the induction of remission in adult patients with mildly to moderately active ulcerative colitis is 2.4 g to 4.8 g (two to four 1.2-g tablets) taken once daily.
The recommended dosage for the maintenance of remission is 2.4 g (two 1.2-g tablets) taken once daily.

Pediatric Patients

The recommended dosage for treatment of mildly to moderately active ulcerative colitis in pediatric patients weighing at least 24 kg who can swallow tablets whole is shown in Table 1:

Table 1: Recommended Dosage of LIALDA for the Treatment of Mildly to Moderately Active Ulcerative Colitis in Pediatric Patients Weighing at least 24 kg
Weight of Pediatric Patient	Once Daily LIALDA Dosage
Weight of Pediatric Patient	Week 0 to Week 8	After Week 8
24 kg to 35 kg	2.4 g (two 1.2-g tablets)	1.2 g (one 1.2-g tablet)
Greater than 35 kg to 50 kg	3.6 g (three 1.2-g tablets)	2.4 g (two 1.2-g tablets)
Greater than 50 kg	4.8 g (four 1.2-g tablets)	2.4 g (two 1.2-g tablets)